J&J Contests FDA-Proposed Cap With Study Championing High SPF Sunscreens
This article was originally published in The Rose Sheet
Executive Summary
Johnson & Johnson is strengthening its stance against FDA's proposed maximum for sun protection factors on sunscreen products with a new study refuting the notion that high SPF formulas cannot be accurately and consistently measured.